exenatide glp 1 GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus Table 3 from Glucagon-Like Peptide-1

Dosing errors with compounded GLP-1 medications have been reported, including cases where patients received doses that were too high or improperly measured

Gregory Westcott, Beth Israel Deaconess Medical Center and Harvard Medical School, United States Updates Copyright 2023 Muller, Stenvers, Malekzadeh, Holleman, Painter and Siegelaar

Graybill et al

Compared with the class of oral diabetes medications called SGLT2 inhibitors, GLP-1 therapies usually result in greater weight loss and stronger blood sugar lowering

For some, its a mild queasiness

Nausea initialization onto GLP-1 therapies can cause significant nausea